BR112017024399B1 - Composição farmacêutica antiviral de uso tópico - Google Patents

Composição farmacêutica antiviral de uso tópico Download PDF

Info

Publication number
BR112017024399B1
BR112017024399B1 BR112017024399-7A BR112017024399A BR112017024399B1 BR 112017024399 B1 BR112017024399 B1 BR 112017024399B1 BR 112017024399 A BR112017024399 A BR 112017024399A BR 112017024399 B1 BR112017024399 B1 BR 112017024399B1
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
antiviral
weight
concentration
cationic
Prior art date
Application number
BR112017024399-7A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112017024399A2 (pt
Inventor
Arganarás Luis Alberto
Original Assignee
Quimica Luar S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quimica Luar S R L filed Critical Quimica Luar S R L
Publication of BR112017024399A2 publication Critical patent/BR112017024399A2/pt
Publication of BR112017024399B1 publication Critical patent/BR112017024399B1/pt

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
BR112017024399-7A 2015-05-15 2016-05-13 Composição farmacêutica antiviral de uso tópico BR112017024399B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ARP20150101519 2015-05-15
ARP150101519A AR100459A1 (es) 2015-05-15 2015-05-15 Una composición farmacéutica antiviral de uso tópico
PCT/ES2016/070365 WO2016185069A1 (es) 2015-05-15 2016-05-13 Una composición farmacéutica antiviral de uso tópico

Publications (2)

Publication Number Publication Date
BR112017024399A2 BR112017024399A2 (pt) 2019-02-05
BR112017024399B1 true BR112017024399B1 (pt) 2022-06-07

Family

ID=57319498

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017024399-7A BR112017024399B1 (pt) 2015-05-15 2016-05-13 Composição farmacêutica antiviral de uso tópico

Country Status (11)

Country Link
US (1) US10478452B2 (es)
EP (1) EP3295934B1 (es)
AR (1) AR100459A1 (es)
BR (1) BR112017024399B1 (es)
CL (1) CL2017002796A1 (es)
CO (1) CO2017011297A2 (es)
ES (1) ES2915824T3 (es)
IL (1) IL255635A (es)
MX (1) MX2017014162A (es)
PE (1) PE20180396A1 (es)
WO (1) WO2016185069A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022219944A1 (ja) * 2021-04-16 2022-10-20 株式会社日本触媒 抗コロナウイルス剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3743727A (en) * 1970-11-16 1973-07-03 Crown Zellerbach Corp Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide
US4902720A (en) * 1983-01-10 1990-02-20 Baldone Joseph A Treatment of virus infections with quaternary ammonium compounds
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
BRPI0014271B1 (pt) * 1999-09-24 2021-06-22 Janssen Pharmaceutica N.V. Partícula consistindo em uma dispersão de sólidos, uso da dita partícula, dispersão de sólidos, forma de dosagem farmacêutica, bem como processos de preparação de dita partícula, dispersão e forma de dosagem
US6855341B2 (en) 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
ITMI20051417A1 (it) * 2005-07-22 2007-01-23 Mipharm S P A Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina
US8119115B2 (en) * 2006-02-09 2012-02-21 Gojo Industries, Inc. Antiviral method
US7883487B2 (en) * 2008-06-16 2011-02-08 Shantha Totada R Transdermal local anesthetic patch with injection port
US20140328895A1 (en) * 2011-03-29 2014-11-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Film-forming composition for a ph-dependant sustained release of the active agent

Also Published As

Publication number Publication date
MX2017014162A (es) 2018-06-20
WO2016185069A1 (es) 2016-11-24
US20180250327A1 (en) 2018-09-06
CO2017011297A2 (es) 2018-01-31
BR112017024399A2 (pt) 2019-02-05
IL255635A (en) 2018-01-31
EP3295934A1 (en) 2018-03-21
EP3295934B1 (en) 2022-03-02
ES2915824T3 (es) 2022-06-27
EP3295934A4 (en) 2019-01-02
CL2017002796A1 (es) 2018-07-13
AR100459A1 (es) 2016-10-05
PE20180396A1 (es) 2018-02-28
US10478452B2 (en) 2019-11-19

Similar Documents

Publication Publication Date Title
US9737498B2 (en) Method for treating an inflammation or lesion caused by a virus
UA79075C2 (uk) Фармацевтична композиція, що містить гіалуронову кислоту та гліцерритинову кислоту, та її застосування
BRPI0613824A2 (pt) composição para tratamento de lesões da pele
ITRM20060163A1 (it) Composizione spray ad uso topico per il tratamento e la prevenzione delle infezioni labiali da herpes simplex
JP2023123440A (ja) 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
CA2439413C (en) Virucidal compositions
AU2002251933A1 (en) Virucidal compositions
BR112017024399B1 (pt) Composição farmacêutica antiviral de uso tópico
BRPI0616449A2 (pt) composição oftálmica, preparação combinada, uso da referida composição e uso de um agente formador de pelìcula
WO1993000114A1 (en) Topical composition enhancing healing of herpes lesions
DK2374461T3 (en) Piroxicam for the prophylactic and therapeutic treatment of herpes infections
BR112019018998A2 (pt) tratamento de sintomas de herpes simples na pele e membrana mucosa de mamíferos
ES2808864T3 (es) Método para tratar enfermedades recurrentes de la piel y la membrana mucosa provocadas por HSV-1 y HSV-2

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/05/2016, OBSERVADAS AS CONDICOES LEGAIS